EPS Bio Technology Corp. (TPEX:4183)

EPS Bio Technology Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	128.94	195.29	178.66	203.42	221.87
Cash & Short-Term Investments	128.94	195.29	178.66	203.42	221.87
Cash Growth	-33.97%	9.31%	-12.17%	-8.32%	26.22%
Accounts Receivable	149.8	92.09	78.81	101.23	80.47
Other Receivables	4.88	2.97	2.27	2.78	2.02
Receivables	154.67	95.05	81.08	104.01	82.48
Inventory	81.06	72.67	86.45	81.56	49.29
Prepaid Expenses	3.15	3.18	1.54	4.06	1.56
Other Current Assets	0.17	0.15	0.06	0.05	0.06
Total Current Assets	368	366.33	347.77	393.1	355.27
Property, Plant & Equipment	167.86	163.14	172.32	173.57	180.51
Other Intangible Assets	1.84	1.96	3.64	5.41	6.83
Long-Term Deferred Tax Assets	1.59	3.38	1.85	2.38	1.91
Other Long-Term Assets	2.61	8.36	2.18	3	2.45
Total Assets	541.9	543.16	527.76	577.45	546.97
Accounts Payable	80.64	74.54	58.31	81.38	56.6
Accrued Expenses	25.02	27.02	26.33	26.88	27.11
Current Portion of Long-Term Debt	2.59	2.55	2.52	2.54	2.5
Current Portion of Leases	3.16	3.14	3.08	3.01	2.96
Current Income Taxes Payable	-	7.28	6.65	8.96	7.93
Current Unearned Revenue	13.19	3.79	1.6	29.29	6.58
Other Current Liabilities	5.26	6.71	4.83	5.12	7.59
Total Current Liabilities	129.85	125.03	103.32	157.17	111.27
Long-Term Debt	10.4	12.98	15.52	18.02	20.56
Long-Term Leases	93.99	97.15	100.28	102.91	105.92
Long-Term Unearned Revenue	2.35	1.78	-	-	-
Long-Term Deferred Tax Liabilities	0.76	0.18	0.28	0.08	0.07
Total Liabilities	237.34	237.13	219.41	278.18	237.82
Common Stock	238	238	238	238	238
Additional Paid-In Capital	31.6	31.6	31.6	31.6	31.6
Retained Earnings	34.95	36.44	38.76	29.67	39.55
Shareholders' Equity	304.55	306.04	308.36	299.27	309.15
Total Liabilities & Equity	541.9	543.16	527.76	577.45	546.97
Total Debt	110.14	115.82	121.4	126.47	131.93
Net Cash (Debt)	18.81	79.47	57.26	76.95	89.95
Net Cash Growth	-76.34%	38.80%	-25.60%	-14.45%	132.67%
Net Cash Per Share	0.79	3.33	2.40	3.22	3.76
Filing Date Shares Outstanding	23.8	23.8	23.8	23.8	23.8
Total Common Shares Outstanding	23.8	23.8	23.8	23.8	23.8
Working Capital	238.15	241.3	244.45	235.93	244
Book Value Per Share	12.80	12.86	12.96	12.57	12.99
Tangible Book Value	302.71	304.08	304.72	293.86	302.33
Tangible Book Value Per Share	12.72	12.78	12.80	12.35	12.70
Buildings	67.87	67.87	68.54	68.86	66.66
Machinery	45.01	39.21	49.02	50.26	50.17
Construction In Progress	2.35	-	-	-	-

Updated Mar 11, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.